9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one

Details

Top
Internal ID af6de76a-ee9e-4eff-a5c2-dd2ba46311e0
Taxonomy Nucleosides, nucleotides, and analogues > Purine nucleosides
IUPAC Name 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one
SMILES (Canonical) C1=NC(=O)C2=C(N1)N(C=N2)C3C(C(C(O3)CO)O)O
SMILES (Isomeric) C1=NC(=O)C2=C(N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O
InChI InChI=1S/C10H12N4O5/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18/h2-4,6-7,10,15-17H,1H2,(H,11,12,18)/t4-,6-,7-,10-/m1/s1
InChI Key UGQMRVRMYYASKQ-KQYNXXCUSA-N
Popularity 108 references in papers

Physical and Chemical Properties

Top
Molecular Formula C10H12N4O5
Molecular Weight 268.23 g/mol
Exact Mass 268.08076950 g/mol
Topological Polar Surface Area (TPSA) 129.00 Ų
XlogP -2.10
Atomic LogP (AlogP) -2.27
H-Bond Acceptor 8
H-Bond Donor 4
Rotatable Bonds 2

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.6680 66.80%
Caco-2 - 0.9502 95.02%
Blood Brain Barrier + 0.6750 67.50%
Human oral bioavailability - 0.8286 82.86%
Subcellular localzation Nucleus 0.4950 49.50%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9207 92.07%
OATP1B3 inhibitior + 0.9504 95.04%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 1.0000 100.00%
BSEP inhibitior - 0.9188 91.88%
P-glycoprotein inhibitior - 0.9166 91.66%
P-glycoprotein substrate - 0.9217 92.17%
CYP3A4 substrate - 0.5657 56.57%
CYP2C9 substrate - 0.6000 60.00%
CYP2D6 substrate - 0.8757 87.57%
CYP3A4 inhibition - 0.9825 98.25%
CYP2C9 inhibition - 0.9637 96.37%
CYP2C19 inhibition - 0.9607 96.07%
CYP2D6 inhibition - 0.9629 96.29%
CYP1A2 inhibition - 0.8425 84.25%
CYP2C8 inhibition - 0.9360 93.60%
CYP inhibitory promiscuity - 0.9540 95.40%
UGT catelyzed + 0.9000 90.00%
Carcinogenicity (binary) - 0.9800 98.00%
Carcinogenicity (trinary) Non-required 0.6628 66.28%
Eye corrosion - 0.9907 99.07%
Eye irritation - 0.9443 94.43%
Skin irritation - 0.7717 77.17%
Skin corrosion - 0.9423 94.23%
Ames mutagenesis + 0.7109 71.09%
Human Ether-a-go-go-Related Gene inhibition - 0.7271 72.71%
Micronuclear + 0.9700 97.00%
Hepatotoxicity + 0.6349 63.49%
skin sensitisation - 0.8686 86.86%
Respiratory toxicity + 0.8556 85.56%
Reproductive toxicity + 0.9556 95.56%
Mitochondrial toxicity + 0.9250 92.50%
Nephrotoxicity - 0.8179 81.79%
Acute Oral Toxicity (c) III 0.5175 51.75%
Estrogen receptor binding - 0.6354 63.54%
Androgen receptor binding + 0.5804 58.04%
Thyroid receptor binding - 0.5156 51.56%
Glucocorticoid receptor binding - 0.4760 47.60%
Aromatase binding + 0.8198 81.98%
PPAR gamma + 0.6782 67.82%
Honey bee toxicity - 0.8729 87.29%
Biodegradation - 0.7750 77.50%
Crustacea aquatic toxicity - 0.8000 80.00%
Fish aquatic toxicity - 0.8379 83.79%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
CHEMBL1293232 Q16637 Survival motor neuron protein 1258.9 nM
Potency
via CMAUP

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 96.47% 96.09%
CHEMBL226 P30542 Adenosine A1 receptor 93.07% 95.93%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 88.26% 94.00%
CHEMBL2581 P07339 Cathepsin D 88.01% 98.95%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 87.33% 99.23%
CHEMBL3401 O75469 Pregnane X receptor 86.72% 94.73%
CHEMBL1806 P11388 DNA topoisomerase II alpha 86.63% 89.00%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 86.10% 95.56%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 85.74% 91.11%
CHEMBL4016 P42262 Glutamate receptor ionotropic, AMPA 2 84.63% 86.92%
CHEMBL3137262 O60341 LSD1/CoREST complex 82.32% 97.09%
CHEMBL3137261 O14744 PRMT5/MEP50 complex 82.22% 100.00%
CHEMBL2850 P49840 Glycogen synthase kinase-3 alpha 82.06% 88.84%
CHEMBL1075162 Q13304 Uracil nucleotide/cysteinyl leukotriene receptor 81.83% 80.33%
CHEMBL5103 Q969S8 Histone deacetylase 10 80.42% 90.08%

Cross-Links

Top
PubChem 6021
NPASS NPC54320
ChEMBL CHEMBL1556
LOTUS LTS0273582
wikiData Q422564